about
Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivoDaclizumab therapy for multiple sclerosisThe role of suppressors of cytokine signalling in human neoplasmsMultiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathwayThe effects of interleukin-2 on immune response regulation.Brain interleukin-15 in neuroinflammation and behavior.The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients.IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes.Essential role of interleukin-15 receptor in normal anxiety behavior.Ontogeny and expansion of human natural killer cells: clinical implications.Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapyMulticytokine detection improves latent tuberculosis diagnosis in health care workersProtection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid.Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancersComparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal ModelsIncreased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.Emerging therapies for multiple sclerosis.Role of IL-2 in cancer immunotherapyIL-15 receptor deletion results in circadian changes of locomotor and metabolic activity.Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesisMolecular pathways: interleukin-15 signaling in health and in cancer.Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits.Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development.Overexpression of Interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin.Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.Population PK-PD analyses of CD25 occupancy, CD56bright NK cell expansion, and regulatory T cell reduction by daclizumab HYP in subjects with multiple sclerosis.Off-target immune cell toxicity caused by AG-012986, a pan-CDK inhibitor, is associated with inhibition of p38 MAPK phosphorylation.Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells.Cytokine tissue levels as markers of disease activity in pediatric Crohn disease.Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression.Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis.Direct regulation of lipolysis by interleukin-15 in primary pig adipocytes.
P2860
Q24671177-72627E0F-3B07-4B31-BA1A-3750839D2D36Q27022517-45B5FED0-01E9-41ED-A177-D6465FFC6E68Q27026783-11D6081E-B2E3-4577-9D30-396CAEED6172Q28365233-6B652EB2-695A-48C1-84E9-49F5C0510387Q30252875-85C9A9F2-C635-4CEC-8D97-18E58D134E96Q30443708-9902D68C-438E-493B-887B-26A216201250Q33941389-04774582-810F-48B4-92BB-582788498E31Q33952031-4077C42A-5C3F-49CA-A3FE-6D445DDCB418Q34161247-100A1E63-B0CF-49B1-85D4-9DC07C51EF04Q34172690-B77E724E-A1CF-41F4-839B-EA4D194BB4DEQ34552167-E592944B-E34C-4231-89AA-71597FD2DB2DQ34596171-12951CA8-23DC-4D0F-B5C6-4095391F5441Q34936175-12D5B8A7-DDEB-4A10-A8D2-A753F8983CDAQ35943027-C6C78EDE-18F2-485C-B34D-0CDD8319EAE5Q36276936-919C72C5-D09E-4780-8D53-608703FC2925Q36375481-9CD9902A-A65E-416C-B0D6-59AE302E9C66Q36436914-9A5F9ABF-9027-4B80-A5E2-BEC2566E3E51Q36825473-A2AAA684-1F00-49EE-9835-165BB8C8E7B5Q36963208-23DC16B8-AC73-45A7-BAB1-A0ACFB401EBEQ37079072-C94E6BF6-E84E-4FEC-9FE4-6AA14236E597Q37612078-81AC975B-FBB8-4DBB-B819-542979EC3CB8Q38068180-47AA4C82-44AD-4F46-A7AC-FBE9AA72F7BAQ38204960-2D5A514A-D300-4768-8992-E904E429F2E7Q39912633-DE8B8BA5-D34D-40AC-A296-85BF0237159FQ40000217-36F82994-C319-4437-858E-92C383964AC9Q40156550-4386603B-370E-43B3-A922-D4F204453528Q40597854-77CB78FE-9F95-4BDB-BA6C-DF54C1E9FF10Q40760682-BF56928D-223B-4DA8-84A9-795D98834012Q40936325-C37C728D-F695-475B-A1B2-F92D4D3B35A5Q41103172-EE375C37-69F9-416B-9AB5-E2AE47A52675Q41875914-FA48BA52-036B-4335-ADAB-18E29A4BAD2EQ42485792-5FB3BE24-04A1-4884-BD44-31AAEB42A53BQ42700892-6C1BC7C2-758E-4795-8230-BA02B5C668BFQ42723787-8143ADE9-A041-4D26-8153-60AB5D320389Q42944594-75D1FA44-861A-4F27-946D-A4EC53B445DEQ43869172-6AF69135-D912-4B0E-B337-16D3E071D254Q43920073-6C8767FB-234D-4321-82E8-1409BBB2709DQ45710670-14ADC2D0-3523-4C9F-883E-657627AD6C34Q46377533-7150709E-1537-4F42-81E0-3077FA236B54Q47449704-4800BC65-7374-4620-911D-601187CB199B
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Interleukin-2, interleukin-15, and their receptors.
@en
type
label
Interleukin-2, interleukin-15, and their receptors.
@en
prefLabel
Interleukin-2, interleukin-15, and their receptors.
@en
P2093
P2860
P1476
Interleukin-2, interleukin-15, and their receptors.
@en
P2093
P2860
P304
P356
10.3109/08830189809042995
P577
1998-01-01T00:00:00Z